ArticleJournal of the American Society for Mass Spectrometry2026
Rapid Antibody Structural Characterization and Quantification via Microdroplet Trypsin Digestion.
Article in Journal of the American Society for Mass Spectrometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Microdroplet digestion of proteins, including monoclonal antibodies (mAbs), has gained increasing attention for its potential in rapid protein structural characterization. In this study, we developed a fast antibody characterization and quantitation method using online microdroplet trypsin digestion. This automated approach involves ultrafast digestion in <1 ms (>90% digestion efficiency) and subsequent MS and MS/MS for peptide mapping and pinpointing peptide modifications. For instance, by MS/MS analysis, the N387 residue rather than N392 and N393 of the "PENNYK" peptide, GFYPSDIAVEWESN387GQPEN392N393YK generated from NIST mAb microdroplet digestion, was found to undergo major deamidation due to its proximity to the G388 residue (upon incubation with a pH 8 Tris buffer for 5 days, ca. 32% of the N387 residue was deamidated). To further demonstrate our method's applications, methionine oxidation, another important type of post-translational modification (PTM) of mAbs, was successfully quantified by spiking the mAb sample with standard peptides for microdroplet digestion. Such an absolute quantitation approach showed a better accuracy for measuring the methionine oxidation level, in comparison to traditional relative quantitation methods, which simply compare ion intensities of oxidized and intact peptides to calculate the oxidation level (the relative quantitation is problematic as the oxidized and intact peptides have different ionization efficiencies). Similarly, by spiking the antibody with a heavy isotope-labeled antibody, our microdroplet digestion method allowed quick absolute antibody quantification, demonstrating good linearity (R2 = 0.99), sensitivity (LOD: 1.2 ng), and accuracy (0.6-10% quantification error in comparison to the theoretical amount of injected antibody).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.